This is fascinating, and a niche where I can definitely see a smaller player causing a splash and driving down prices for nuclear medicine.

My question is, how equipped are you to handle regulatory hurdles for international customers? It's one thing for a small firm to deal with US civil nuclear regulations, but how are you going to deal with the regulators of each foreign market you intend to export to? I imagine that this is something that the larger providers in the field use economies of scale to deal with, but could be a hurdle for a startup.